Bioresorbable vascular scaffolds may be just as effective as drug-eluting metal stents for treating heart disease patients : vimarsana.com

First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic stents, which are currently the standard treatment for heart disease patients undergoing percutaneous coronary intervention (PCI).

Related Keywords

United States , Paris , France General , France , Lily Ramsey , Population Health Science , Icahn School Of Medicine At Mount Sinai , European Association Of Percutaneous Cardiovascular Interventions , Drug Administration , Journal Of The American College Cardiology , Icahn School , Late Breaking Clinical , European Association , Percutaneous Cardiovascular Interventions , American College , Lead Author , Academic Affairs , Mount Sinai Health System , Icahn Mount , Seattle Angina Questionnaire , Visual Analog Scale , Heart , Eart Disease , Ngina , Lood , Ardiology , Hest Pain , Hildren , Linical Trial , Oronary Artery Disease , Rug Eluting Stent , Verolimus , Eriatrics , Ealth Care , Eart Attack , Ospital , Edicine , Ain , Esearch , Tent , Urgery , Echnology , Hrombosis , Ascular ,